Skip to main content

PAVmed Inc.

PAVM
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001624326

No open-market purchases or sales by PAVmed Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $5.56M in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding PAVmed Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of PAVM: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders7673−3
Shares12.1M12.7M+572.9K (+4.7%)
Value$11.5M$10.9M−$528.0K (−4.6%)

New holders (11)

Institutions that held PAVmed Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to PAVM in Q3 2022
InstitutionSharesValue% of portfolio
Ayrton Capital LLC1,599,961$1.38M2.41%
Kestra Private Wealth Services, LLC1,000,207$860.0K0.05%
WealthPlan Investment Management, LLC32,100$20.0K0.00%
Mariner, LLC13,912$12.0K0.00%
HRT Financial LP15,000$12.0K0.00%
Mercer Global Advisors Inc11,567$10.0K0.00%
Creative Planning11,814$10.0K0.00%
Ground Swell Capital, LLC10,378$9.00K0.03%
Washburn Capital Management, Inc.10,000$9.00K0.01%
Royal Bank of Canada515$00.00%
Bogart Wealth, LLC150$00.00%

Sold out (14)

Institutions that held PAVmed Inc. at the end of Q2 2022 and filed for Q3 2022 without it.